Refine your results

to


Search

Vagal nerve-blocking therapy safe, effective in type 2 diabetes, obesity

Show Citation

February 16, 2017

AUTHORS:

Herrera MF, Toouli J, Kulseng B, Brancatisano R, Kow L, Pantoja JP, Johnsen G, Brancatisano A, Tweden KS, Waataja JJ, Billington CJ, Shikora SA.

BACKGROUND:

The VBLOC DM2 study demonstrated that intermittent electrical vagal blocking (vBloc therapy) was safe among subjects with obesity and type 2 diabetes mellitus (DM2) and led to clinically meaningful improvement in weight loss and glycemic parameters at 2 years. Sustainability of these responses at three years is reported here. ...

Advertisement
Advertisement